Biomarker correlation with endoscopic outcomes in patients with Crohn's disease: data from CALM
Management of Crohn’s disease (CD) is moving towards the therapeutic goal of mucosal healing and using biomarkers of inflammation, faecal calprotectin (FC) and C-reactive protein (CRP), to monitor patient progress. CALM demonstrated superior mucosal healing in patients whose treatment was escalated...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Oxford University Press
2018
|